Cargando…

BICD Cargo Adaptor 1 (BICD1) Downregulation Correlates with a Decreased Level of PD-L1 and Predicts a Favorable Prognosis in Patients with IDH1-Mutant Lower-Grade Gliomas

SIMPLE SUMMARY: The hypoxic inducible factor 1A (HIF1A) pathway has been known to play an important role in tumor progression in various cancers, including lower-grade (Grade II/III) gliomas (LGGs). An in silico analysis using 34 genes associated with the activity of the HIF1A pathway demonstrated t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shang-Pen, Li, Chien-Hsiu, Chang, Wei-Min, Lin, Yuan-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389329/ https://www.ncbi.nlm.nih.gov/pubmed/34439934 http://dx.doi.org/10.3390/biology10080701

Ejemplares similares

Golgi-associated BICD adaptors couple ER membrane penetration and disassembly of a viral cargo
por: Spriggs, Chelsey C., et al.
Publicado: (2020)

PTPN23 binds the dynein adaptor BICD1 and is required for endocytic sorting of neurotrophin receptors
por: Budzinska, Marta I., et al.
Publicado: (2020)

BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas
por: Huang, Shang-Pen, et al.
Publicado: (2017)

Coil-to-α-helix transition at the Nup358-BicD2 interface activates BicD2 for dynein recruitment
por: Gibson, James M, et al.
Publicado: (2022)

Dynein activating adaptor BICD2 controls radial migration of upper-layer cortical neurons in vivo
por: Will, Lena, et al.
Publicado: (2019)

BICD2, dynactin, and LIS1 cooperate in regulating dynein recruitment to cellular structures
por: Splinter, Daniël, et al.
Publicado: (2012)

Biallelic Loss-of-Function Variants in BICD1 Are Associated with Peripheral Neuropathy and Hearing Loss
por: Hirsch, Yoel, et al.
Publicado: (2023)

Elevated BICD2 DNA methylation in blood of major depressive disorder patients and reduction of depressive-like behaviors in hippocampal Bicd2-knockdown mice
por: Xiu, Jianbo, et al.
Publicado: (2022)

The mRNA transportome of the BicD/Egl transport machinery
por: Vazquez-Pianzola, Paula, et al.
Publicado: (2016)

Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease
por: Hao, Wenyan, et al.
Publicado: (2023)

BICD1 mediates HIF1α nuclear translocation in mesenchymal stem cells during hypoxia adaptation
por: Lee, Hyun Jik, et al.
Publicado: (2018)

FIGNL1 associates with KIF1Bβ and BICD1 to restrict dynein transport velocity during axon navigation
por: Atkins, Melody, et al.
Publicado: (2019)

Disease-associated mutations in human BICD2 hyperactivate motility of dynein–dynactin
por: Huynh, Walter, et al.
Publicado: (2017)

Biallelic BICD2 Variant is a Novel Candidate for Cohen-Like Syndrome
por: Caglayan, Ahmet Okay, et al.
Publicado: (2022)

A Structural Model for the Core Nup358-BicD2 Interface
por: Gibson, James M., et al.
Publicado: (2023)

Dominant spinal muscular atrophy is caused by mutations in BICD2, an important golgin protein
por: Martinez-Carrera, Lilian A., et al.
Publicado: (2015)

In-frame de novo mutation in BICD2 in two patients with muscular atrophy and arthrogryposis
por: Koboldt, Daniel C., et al.
Publicado: (2018)

A homozygous loss-of-function variant in BICD2 is associated with lissencephaly and cerebellar hypoplasia
por: Abdel-Salam, Ghada M. H., et al.
Publicado: (2022)

BICD2 phosphorylation regulates dynein function and centrosome separation in G2 and M
por: Gallisà-Suñé, Núria, et al.
Publicado: (2023)

Overexpression of PSAT1 Gene is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients with IDH1 Mutations and Chromosome 1p19q Codeletion
por: Huang, Shang-Pen, et al.
Publicado: (2019)

Role of Nesprin-2 and RanBP2 in BICD2-associated brain developmental disorders
por: Yi, Julie, et al.
Publicado: (2023)

Microscopic and Biochemical Hallmarks of BICD2-Associated Muscle Pathology toward the Evaluation of Novel Variants
por: Unger, Andreas, et al.
Publicado: (2023)

Role of BicDR in bristle shaft construction, tracheal development, and support of BicD functions
por: Jejina, Aleksandra, et al.
Publicado: (2023)

Identification and functional characterization of BICD2 as a candidate disease gene in an consanguineous family with dilated cardiomyopathy
por: Luo, Kai, et al.
Publicado: (2022)

Methylation of PD-1 Promoter Gene as New Prognostic Marker for IDH Mutant Low-Grade Glioma?
por: Marosi, Christine
Publicado: (2018)

Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy
por: Rossor, Alexander M., et al.
Publicado: (2020)

Systematic Functional Analysis of Bicaudal-D Serine Phosphorylation and Intragenic Suppression of a Female Sterile Allele of BicD
por: Koch, Rafael, et al.
Publicado: (2009)

The p.Ser107Leu in BICD2 is a mutation ‘hot spot’ causing distal spinal muscular atrophy
por: Bansagi, Boglarka, et al.
Publicado: (2015)

DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells
por: Li, Hongyang, et al.
Publicado: (2017)

Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma()()
por: Sun, Chao, et al.
Publicado: (2020)

Impairment in dynein-mediated nuclear translocation by BICD2 C-terminal truncation leads to neuronal migration defect and human brain malformation
por: Tsai, Meng-Han, et al.
Publicado: (2020)

Metabolic Reprogramming in Mutant IDH1 Glioma Cells
por: Izquierdo-Garcia, Jose L., et al.
Publicado: (2015)

Mutant IDH1 Promotes Glioma Formation In Vivo
por: Philip, Beatrice, et al.
Publicado: (2018)

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
por: Mellinghoff, Ingo K., et al.
Publicado: (2023)

Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner
por: Viswanath, Pavithra, et al.
Publicado: (2018)

CBMS-1 TARGETING GLUTAMINE METABOLISM IN IDH-MUTANT GLIOMAS
por: Ohba, Shigeo, et al.
Publicado: (2022)

PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas
por: Koncar, Robert F., et al.
Publicado: (2017)

Mutant IDH1 Depletion Downregulates Integrins and Impairs Chondrosarcoma Growth
por: Li, Luyuan, et al.
Publicado: (2020)

CBMS-1 Targeting amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas
por: Ohba, Shigeo, et al.
Publicado: (2021)

Mutant IDH1 regulates the tumor-associated immune system in gliomas
por: Amankulor, Nduka M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o4j2kb15m8h8epilisivf5e23k